A complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice

• Published in: Journal of Neural Transmission 2011-11, Vol.118 (11), p.1535-1546
• Main Authors: Poleszak, Ewa, Wlaź, Piotr, Szewczyk, Bernadeta, Wlaź, Aleksandra, Kasperek, Regina, Wróbel, Andrzej, Nowak, Gabriel
• Format: Article
• Language: English
• Subjects: Adrenergic Agonists - pharmacology; Animals; Antagonists; Antidepressants; Antidepressive Agents - pharmacology; Basic Neurosciences; Basic Neurosciences, Genetics and Immunology - Original; Cycloserine; D-Serine; Depressive Disorder - drug therapy; Depressive Disorder - metabolism; Depressive Disorder - physiopathology; Disease Models, Animal; Drugs; Fluoxetine; Genetics and Immunology - Original Article; Glutamic acid receptors (ionotropic); Glycine; imipramine; Locomotor activity; Male; Medicine; Medicine & Public Health; Mice; N-Methyl-D-aspartic acid receptors; Nerve endings; Neurology; Neurosciences; Norepinephrine; Psychiatry; reboxetine; Receptors, Glycine - chemistry; Receptors, Glycine - metabolism; Receptors, N-Methyl-D-Aspartate - chemistry; Receptors, N-Methyl-D-Aspartate - metabolism; Serotonin; Serotonin Receptor Agonists - pharmacology; Serotonin receptors; Stress, Psychological - drug therapy; Stress, Psychological - metabolism; Stress, Psychological - physiopathology; Swimming - psychology
• ISSN: 0300-9564; 1435-1463
• DOI: 10.1007/s00702-011-0630-9

Both clinical and preclinical studies demonstrate the antidepressant activity of the functional NMDA receptor antagonists. In this study, we assessed the effects of two glycine/NMDA receptor ligands, namely L-701,324 (antagonist) and d -cycloserine (a partial agonist) on the action of antidepressant drugs with different pharmacological profiles in the forced swim test in mice. Swim sessions were conducted by placing mice individually in glass cylinders filled with warmed water for 6 min. The duration of behavioral immobility during the last 4 min of the test was evaluated. The locomotor activity of mice was measured with photoresistor actimeters. L-701,324 and d -cycloserine given with reboxetine (administered in subeffective doses) did not change the behavior of animals in the forced swim test. A potentiating effect was seen when both tested glycine site ligands were given concomitantly with imipramine or fluoxetine in this test. The lesion of noradrenaline nerve terminals produced by DSP-4 neither altered the baseline activity nor influenced the antidepressant-like action of L-701,324 or d -cycloserine. The depletion of serotonin by p -CPA did not alter baseline activity in the forced swim test. However, it completely antagonized the antidepressant-like action produced by L-701,324 and d -cycloserine. Moreover, the antidepressant-like effects of imipramine, fluoxetine and reboxetine were abolished by d -serine, a full agonist of glycine/NMDA receptors. The present study demonstrates that glycine/NMDA receptor functional antagonists enhance the antidepressant-like action of serotonin, but not noradrenaline-based antidepressants and such their activity seems to depend on serotonin rather than noradrenaline pathway.